Product Information
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.2019 per ML under NDC 72205007072. Its NADAC has been published 48 times since Nov 5, 2025.
FDA first approved this application on Apr 8, 2025. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/5mL
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205007072
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA216084FDA Approved
4/8/2025
TE Code
AA
On Market Since
4/8/2025
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has been published 48 times since Nov 5, 2025, and over the history we have for it it has declined 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2019 per ML |
|---|---|
| All-time high | $0.2491 (Feb 11, 2026) |
| All-time low | $0.1689 (May 20, 2026) |
| 52-week high | $0.2491 |
| 52-week low | $0.1689 |
| Median price | $0.2023 |
| Average price | $0.2052 |
| Largest weekly change | -15.1% (Feb 18, 2026) |
| Weeks tracked | 48 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GLYCOPYRROLATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
GLYCOPYRROLATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION, manufactured by Novadoz Pharmaceuticals LLC, is $0.2019 per ML (NDC 72205007072), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has declined 10.3%. It has been tracked across 48 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
Since Nov 5, 2025, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has ranged from a low of $0.1689 (May 20, 2026) to a high of $0.2491 (Feb 11, 2026), with a median of $0.2023 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION (NDC 72205007072) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.